Vishnumurthy Hegde

Title: **Innovations by Vishnumurthy Hegde: A Leader in Vitamin D Research**

Introduction

Vishnumurthy Hegde, based in Chelmsford, MA, is an accomplished inventor with a remarkable portfolio of 14 patents. His pioneering work focuses on the development of therapeutic vitamin D conjugates aimed at improving the bioavailability and effectiveness of this essential nutrient.

Latest Patents

Among his latest patents, Vishnumurthy Hegde has made significant strides with innovations that provide non-hormonal vitamin D conjugated to apelin proteins. This invention results in increased absorption, bioavailability, or circulating half-life when compared to non-conjugated forms. Additionally, he has developed a parathyroid hormone (PTH) compound comprising a PTH peptide that boasts significantly increased bioavailability or circulating half-life compared to its native form. These compounds demonstrate greater serum concentration at various time points post-administration in studies with rats, promising advancements in therapeutic applications.

Career Highlights

Hegde has an impressive career marked by his contributions to companies such as Extend Biosciences, Inc. and Saladax Biomedical Inc. His expertise in biochemistry and medicinal chemistry has driven developments that have the potential to revolutionize vitamin D therapies and improve patient outcomes.

Collaborations

Throughout his journey, Vishnumurthy Hegde has collaborated with notable professionals such as Howard Paul Sard and Tarik Soliman. These partnerships have facilitated the creation of innovative solutions in the field of vitamin D therapeutics.

Conclusion

Vishnumurthy Hegde stands out as a key inventor in the realm of vitamin D research, contributing to advancements that could enhance therapeutic practices. With a strong commitment to innovation and collaboration, he continues to pave the way for future discoveries in the medical field.